First Horizon Advisors’s Sage Therapeutics SAGE Stock Holding History

First Horizon Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9	Hold	1	–	–	﹤0.01%	2313
2025 Q1	$8	Hold	1	–	–	﹤0.01%	2302
2024 Q4	$5	Hold	1	–	–	﹤0.01%	2267
2024 Q3	$7	Hold	1	–	–	﹤0.01%	2308
2024 Q2	$11	Hold	1	–	–	﹤0.01%	2277
2024 Q1	$19	Hold	1	–	–	﹤0.01%	2283
2023 Q4	$22	Hold	1	–	–	﹤0.01%	2356
2023 Q3	$21	Hold	1	–	–	﹤0.01%	2378
2023 Q2	$47	Hold	1	–	–	﹤0.01%	2433
2023 Q1	$42	Hold	1	–	–	﹤0.01%	2447
2022 Q4	$38	Hold	1	–	–	﹤0.01%	2439
2022 Q3	$0	Hold	1	–	–	﹤0.01%	2430
2022 Q2	$0	Sell	1 -14	-93%	-$469	﹤0.01%	2520
2022 Q1	$0	Sell	15 -37	-71%	-$1.39K	﹤0.01%	2195
2021 Q4	$2K	Hold	52	–	–	﹤0.01%	2004
2021 Q3	$2K	Buy	52 +33	+174%	+$1.51K	﹤0.01%	2014
2021 Q2	$1K	Buy	19 +9	+90%	+$636	﹤0.01%	1906
2021 Q1	$0	Buy	+10	New	+$820	﹤0.01%	1977
2020 Q1	–	Sell	-226	Closed	-$16K	–	1543
2019 Q4	$16K	Hold	226	–	–	﹤0.01%	949
2019 Q3	$31K	Hold	226	–	–	﹤0.01%	692
2019 Q2	$40K	Hold	226	–	–	﹤0.01%	631
2019 Q1	$35K	Buy	226 +46	+26%	+$6.66K	﹤0.01%	618
2018 Q4	$17K	Hold	180	–	–	﹤0.01%	859
2018 Q3	$24K	Hold	180	–	–	﹤0.01%	821
2018 Q2	$27K	Buy	180 +124	+221%	+$19.5K	﹤0.01%	792
2018 Q1	$8K	Buy	+56	New	+$9.51K	﹤0.01%	1077

Other funds holding SAGE

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

First Horizon Advisors's SAGE Position: Q2 2025 in Review

First Horizon Advisors held its Sage Therapeutics (SAGE) position steady in Q2 2025 at 1 share worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

First Horizon Advisors first reported a position in SAGE in Q1 2018 and has held it in 26 quarters since. The position peaked at $40K in Q2 2019. 192 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

First Horizon Advisors held 1 share of Sage Therapeutics worth $9 as of Q2 2025.
First Horizon Advisors left its Sage Therapeutics share count unchanged in Q2 2025.
Sage Therapeutics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2313 holding.
First Horizon Advisors first reported a position in Sage Therapeutics in Q1 2018 and has held it in 26 quarters since.
First Horizon Advisors's Sage Therapeutics position peaked at $40K in Q2 2019.
192 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.